Dendreon One of the Few Winners Today

Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corp. (NASDAQ:DNDN) shares managed to move up 7.8% on a dismal day for equities, DNDN shares are now back to $38 per share.

Dendreon's Five Day 25% Fall (DNDN)

Dendreon Corporation (NASDAQ:DNDN)

If you were waiting for a pullback on Dendreon Corp. (NASDAQ:DNDN) shares, here's your chance.  In just five trading sessions Dendreon shares have dropped from $34.50 to $26, and today they have managed to get back to $27.80.  Buy on the dip or could more pain be coming?

New 52-Week High for Dendreon Shares, FDA Approves Provenge

Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corporation's (NASDAQ:DNDN) Provenge has been approved by the FDA, it costs $50,000 to $100,000 for treatment, hello $57 a share.

Dendreon Corp. Shares Hit New 52-week High

Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corp. (NASDAQ:DNDN) shares touched $42.60 today, that makes a 12 month 109% gain as investors anxiously await on the May 1st decision on the company's multi billion dollar drug Provenge.

All Eyes on Dendreon Corp. (DNDN)

Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corporation (NASDAQ:DNDN) could have an instant $1 billion in sales if the FDA votes to approve the company's cancer treatment drug Provenge on May 1st.  Dendreon shares have increased 700% in the last 12 months, but come May if the company gets the green light, its going to be a gold rush.

Syndicate content

WallStNation.comThanks for visiting WallStNation.com, to assist your investing research try using our Search (click to access) or review the list of Tickers (click to access) that link directly to articles related to the given stock/security.

To Browse our Most Recent Stories (click here)


Share WallStNation.com Content

Share this article with others, WallStNation.com is the Independent Wall Street Newspaper. Thanks for Reading!

Daily Market Summary




Please Review the WallStNation.com Disclaimer and remember that information provided by our site is at the investor's sole financial risk. Please Review for more Details